Is Cardiology’s Biggest Reversal Coming?
When it came time to write about the CLOSURE-AF trial of percutaneous left atrial appendage closure (LAAC) vs…
Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? Medscape Rivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary…
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you’re often the first healthcare professional that will identify cardiac issues, including…
Your Patient’s Smartwatch Could Be a Legal Time Bomb
A few years ago, a patient in her 30s saw Nicholas Dragolea, MBBS, a general practitioner when her…
Anticoagulants in AF Post-ICH: The Dilemma Continues
TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…
Can Cardiology’s Oldest Drug Make a Comeback?
Cardiac glycosides derived from the foxglove plant have been used in cardiology for two centuries, but digoxin and…